SCHEMBL3169880

SCHEMBL3169880

COc1ccc(N2CCN(CC(=O)Nc3cc(NCCNC(C)=O)nc(-c4ccccc4)n3)CC2C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 7/20 0.46
▸ KDM4E B2RXH2 7/20 0.45
▸ MAPT P10636 6/20 0.45
▸ ALDH1A1 P00352 6/20 0.45
▸ HPGD P15428 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ HSD17B10 Q99714 2/20 0.43
▸ USP2 O75604 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ CHRM4 P08173 1/20 0.41
▸ HTT P42858 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3165629 0.92 GSK3B (0.40) ADORA3KDM4EMAPTALDH1A1HPGD
SCHEMBL3165286 0.87 USP2 (0.57) ADORA3KDM4EMAPTALDH1A1MEN1
SCHEMBL3162603 0.87 GSK3B (0.48) KDM4EMAPTALDH1A1HPGDMEN1
SCHEMBL3171564 0.86 CHRM4 (0.45) ADORA3ALDH1A1TP53MAPK1CHRM4
SCHEMBL3162796 0.84 ADORA3 (0.53) ADORA3ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL3164888 0.83 ADORA3 (0.48) ADORA3MAPTMEN1KMT2AUSP2
SCHEMBL3156668 0.82 MAPT (0.59) MAPTALDH1A1MEN1KMT2AUSP2
SCHEMBL3156575 0.81 ADORA3 (0.48) ADORA3MAPTALDH1A1MEN1KMT2A
SCHEMBL3169692 0.80 ADORA3 (0.47) ADORA3MAPTALDH1A1KMT2AUSP2
SCHEMBL3156070 0.80 TSHR (0.54) ADORA3KDM4EMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback